2 CDMO's Poised For Growth

In this episode, we dive deep into two contract development and manufacturing (CDMO) businesses—Aarti Pharma Labs and Jubilant Pharma—that are riding strong structural trends.
🔬 Learn how the pharma value chain works
📈 Understand key mental models behind successful CDMOs
🚀 Discover growth drivers, J-curve business models & risk factors
💡 Bonus: How these companies are shifting from cash cow APIs to scalable CDMO businesses

Perfect for investors looking to identify the next big wave in healthcare manufacturing.